Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03585959 · ClinicalTrials.gov registry record · NA
superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03585959 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 50 participants.
The verdict
NCT03585959, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this investigation is to confirm the clinical accuracy of the superDimension™ Navigation System Version 7.2 with Fluoroscopic Navigation Technology.
Interventions
- DEVICE superDimension™ Navigation System Version 7.2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-08-03 |
| Est. Completion | 2019-02-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03585959
The ClinicalTrials.gov registry entry for NCT03585959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which superDimension™ Navigation System Version 7.2 is the first listed.
NCT03585959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03585959 about?
NCT03585959 is a clinical study titled "superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology". The purpose of this investigation is to confirm the clinical accuracy of the superDimension™ Navigation System Version 7.2 with Fluoroscopic Navigation Technology.
What is the current status of trial NCT03585959?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-08-03. Estimated completion is 2019-02-18.
What interventions are being tested in trial NCT03585959?
The interventions under investigation include: superDimension™ Navigation System Version 7.2 (DEVICE).
Who is sponsoring clinical trial NCT03585959?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.